Local Institution

New Haven, Connecticut 06520

0 studies enrolling now · 11 studies all time

What they study most

Advanced Cancer, Alcoholism, Bipolar Disorder, Bladder Cancer, Bladder Neoplasms, Breast Cancer, Heart Disease, Hepatitis B, Ischemic Heart Disease, Kawasaki Disease, Kidney Neoplasms, Melanoma

Studies at this site

• A First-in-Human Study of D-0502 Alone and in Combination With Palbociclib in Women With Advanced or Metastatic ER-Positive and HER2-Negative Breast Cancer — Completed
• An Investigational Immunotherapy Study of BMS-986299 Alone and in Combination With Nivolumab and Ipilimumab in Participants With Solid Cancers That Have Spread or Cannot be Removed — Stopped early
• A Study to Evaluate the Use and Safety of CARDIOLITE® in Pediatric Patients With Kawasaki Disease — Completed
• A Study to Examine MPI SPECT Imaging With BMS068645 and Adenosine Compared to Coronary Angiography — Stopped early
• Aripiprazole in Patients With Acute Mania — Completed
• Study of Aripiprazole in Subjects With Alcoholism — Completed
• Combination of Anti-CD137 & Ipilimumab in Patients With Melanoma — Withdrawn before enrolling
• Study of Adding Entecavir to Current Lamivudine Therapy in HIV and HBV Co-Infected Patients — Completed
• A Study to Evaluate the Preliminary Efficacy Pharmacokinetics and Immunogenicity of BMS-188667 Administered to Subjects With Relapsing-remitting Multiple Sclerosis — Stopped early
• Vinflunine in Patients With Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium — Completed
• Study of BMS-275183 in Patients With Pre-treated Non-small Cell Lung Cancer — Stopped early